This article is more than 5 years old. Information may no longer be current.
Zimmer Biomet receives FDA 510(k) clearance for robotically assisted knee system
Click Here to Manage Email Alerts
Zimmer Biomet Holdings Inc. announced it received FDA 510(k) clearance for its Rosa Knee System for robotically assisted total knee replacement surgeries.
Designed to help surgeons in performing total knee replacement surgery, the Rosa Knee assists with bone resections and assesses the state of soft tissues to facilitate implant positioning intraoperatively, according to a company press release. Providing a continuum of data analysis, the system assists in complex decision-making and allows for greater precision and flexibility during procedures by enabling the use of computer and software technology to control and move surgical instruments. Rosa Knee also allows surgeons to personalize procedures and improve outcomes by featuring Zimmer Biomet’s proprietary X-Atlas imaging protocol and intraoperative, real-time mapping of a patient’s anatomy and motion, according to the release.
“We are excited for the launch of Rosa Knee, which brings together Zimmer Biomet’s robotics technology with our industry-leading knee implants to help surgeons personalize surgical procedures for their patients,” Ivan Tornos, group president of orthopedics, said in the release. “Zimmer Biomet is committed to leading the industry in bringing differentiated and holistic solutions to market that address the needs of our customers and improve patient outcomes.”
Reference: